Category: Workers Comp

499 posts found

Healthesystems at NWCDC 2019

Join Healthesystems at booth #1922, at an educational presentation, or by taking our industry survey with Risk & Insurance.

NKTR-181 (loxicodegol) was to receive an approval decision by August 29th, but a reevaluation of opioid policy has resulted in a delay.

Healthesystems’ clinical leaders speak to mitigation strategies to reduce workplace injuries stemming from fatigue.

The utilization of opioids, compounds, and physician-dispensed medications have significantly decreased.

Proposed changes to who can grow and research marijuana will soon be available for public commentary.

An Oklahoma judge found the drug maker to be partially responsible for the harm of the opioid epidemic.

Healthesystems’ Chief Medical Officer explores trends impacting workers’ comp, including patient engagement, population health, and more.

Nine generic versions of Lyrica (pregabalin) have been approved for the treatment of five different medical conditions.

Sandy Shtab has been recognized for making significant contributions to the workers’ comp industry.

Looking at over 29 billion private health claims, this study found that claim lines related to telehealth rose 624% from 2014-2018.

While many states report fewer opioid prescriptions, MME levels vary more significantly by state.

NCCI estimates that a 25-75% reduction in motor vehicle accidents in workers’ comp could save $1-4 billion, creating interest in self-driving cars.

Generic versions of Ultram (tramadol hydrochloride) tablets and Dyloject (diclofenac sodium) injections have been approved by the FDA.

While the utilization of opioids and other problematic drugs decreased, similar drops were seen in states without closed formularies.

Stephanie Arkelian has been recognized as a talented young professional making a positive impact on the workers’ comp industry.

Prev 1 2 3 4 5 … 25 26 27 28 29 30 31 32 33 34 Next